Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

NCT00687544 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepacivirus
HIV Infections

Interventions

BIOLOGICAL: Peginterferon alfa-2b (SCH 054031)
DRUG: Ribavirin (SCH 018908)

Sponsor

Merck Sharp & Dohme LLC